Your browser doesn't support javascript.
loading
EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma.
Lim, Mir; Franses, Joseph W; Imperial, Robin; Majeed, Umair; Tsai, Jill; Hsiehchen, David.
Afiliación
  • Lim M; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Franses JW; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Imperial R; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
  • Majeed U; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
  • Tsai J; Guardant Health Inc, Redwood City, California.
  • Hsiehchen D; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: gbtwnow@gmail.com.
Gastroenterology ; 164(6): 1006-1008.e3, 2023 05.
Article en En | MEDLINE | ID: mdl-36708791
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Gastroenterology Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Gastroenterology Año: 2023 Tipo del documento: Article